A phase III study of Sulopenem for complicated intra-abdominal infections (cIAI)

Trial Profile

A phase III study of Sulopenem for complicated intra-abdominal infections (cIAI)

Planning
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Sulopenem (Primary)
  • Indications Intra-abdominal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jul 2017 According to an Iterum Therapeutics media release, company anticipates initiation of this clinical trial in 2018.
    • 11 Jan 2017 New trial record
    • 05 Jan 2017 According to an Iterum Therapeutics media release, the company anticipates to commence this study under Special Protocol Assessment (SPA) with the United States Food and Drug Administration (FDA) and Scientific Advice from the European Medicines Agency (EMA) by the end of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top